{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-201376","form_type":"8-K","ticker":"FBLG","cik":"0001958777","company_name":"FibroBiologics, Inc.","filed_at":"2026-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.322056+00:00","generated_at":"2026-05-15T00:23:11.854547+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"FibroBiologics enters $6.15M ATM offering with H.C. Wainwright","bullets":["Up to $6.15M of common stock may be sold via at-the-market offering with H.C. Wainwright.","H.C. Wainwright receives 3.0% commission on gross proceeds plus $100K legal reimbursement.","Net proceeds used for working capital and general corporate purposes.","Shares will be sold under existing S-3 shelf (Reg. No. 333-284663).","Company not obligated to sell any shares; no assurance on price or timing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-201376","json":"https://secwatch.observer/filing/0001193125-26-201376.json","markdown":"https://secwatch.observer/filing/0001193125-26-201376.md","text":"https://secwatch.observer/filing/0001193125-26-201376.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958777/000119312526201376/0001193125-26-201376-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958777/000119312526201376/fblg-20260501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:23:11.854547+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c223c1ed35e6ff44d69bb82c43f9bdba454f2a1","claim":"FibroBiologics, Inc. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC valued at up to $6,150,000 (effective 2026-05-01).","evidence_excerpt":"On May 1, 2026, FibroBiologics, Inc. (the “Company”) entered into an At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “Sales Agent”) under which the Company may issue and sell in a registered offering shares of its common stock, par value $0.00001 per share (the “Common Stock”), having an aggregate offering price of up to $6,150,000","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1958777/000119312526201376/0001193125-26-201376-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"},{"label":"Value","value":"up to $6,150,000"},{"label":"Effective","value":"2026-05-01"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}